MMP2 and central nervous system cancer: Nevertheless, since radiotherapy is the standard treatment for glioma and malignant glioma is one of the most radioresistant tumor types, the administration of p-MMP-2 prior to radiotherapy could be a potent adjuvant therapeutic approach to improve the efficacy of radiotherapy for glioma.